ResMed (RMD) operating cash flow was $1.8B in FY2026 (+3% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2026
$1.8B
+3%
2025
$1.8B
+25%
2024
$1.4B
+102%
2023
$693M
+97%
2022
$351M
-52%
2021
$737M
-8%
2020
$802M
+75%
2019
$459M
-9%
2018
$505M
+22%
2017
$414M
-24%
2016
$548M
+43%
2015
$383M
-2%
2014
$391M
-3%
2013
$403M
+5%
2012
$383M
+35%
2011
$283M
+50%
2010
$188M
-21%
2009
$239M
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q2 2026
$455M
Q1 2026
$554M
Q4 2025
$340M
Q3 2025
$457M
Q2 2025
$539M
Q1 2025
$579M
Q4 2024
$309M
Q3 2024
$326M
Q2 2024
$440M
Q1 2024
$402M
Q4 2023
$273M
Q3 2023
$286M
Source: RMD on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.